𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

✍ Scribed by Tadashi Ikeda; Andrew M. L. Lever; Professor Howard C. Thomas


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
406 KB
Volume
6
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Ninety per cent of patients infected in adult life with the hepatitis B virus clear the virus completely and 10% develop chronic infection. There is evidence for the involvement of interferon in the clearance of acute hepatitis B virus infection. We report that, in in vitro tests, some hepatitis B virus carriers have a reduced capacity to produce a-and y-interferon which is unrelated to the level of viral replication and to the severity of the liver disease and that the level of 2-5 oligoadenylate synthetase in their livers is only minimally elevated compared to controls. Treatment with lymphoblastoid (a-) interferon leads to a marked rise in 2-5 oligoadenylate synthetase activity. These data indicate that some patients with chronic hepatitis B virus infection acquired in adult life have a partial deficiency of production of a-interferon but can respond to exogenous a-interferon. These observations provide a logical basis for attempts to treat this condition with interferons.


πŸ“œ SIMILAR VOLUMES


Long-term beneficial effect of interfero
✍ Shi-Ming Lin; I-Shyan Sheen; Rong-Nan Chien; Chia-Ming Chu; Yun-Fan Liaw πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 60 KB πŸ‘ 2 views

To examine the long-term effect of interferon (IFN) therapy in patients with chronic hepatitis B virus (HBV) infection, particularly on survival and hepatocellular carcinoma (HCC) prevention, 101 male patients with chronic hepatitis B in a randomized controlled trial were followed up for 1.1 to 11.5

A randomised controlled trial of recombi
✍ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNΞ³) 0.1 mg/m^2^ intramuscularly thrice weekly for

Meeting vaccination quality measures for
✍ Jennifer R. Kramer; Christine Y. Hachem; Fasiha Kanwal; Minghua Mei; Hashem B. E πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 1 views

Coinfection with hepatitis A virus (HAV) or hepatitis B virus (HBV) in patients with chronic hepatitis C virus (HCV) is associated with increased morbidity and mortality. The Center for Medicare and Medicaid Services has identified HAV and HBV vaccination as a priority area for quality measurement i

Infection of B cells with hepatitis C vi
✍ Momoko Inokuchi; Takayoshi Ito; Manabu Uchikoshi; Yuu Shimozuma; Kenichi Morikaw πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 1 views

## Abstract Infection with hepatitis C virus (HCV) is associated with lymphoproliferative disorders, represented by essential mixed cryoglobulinemia and B‐cell non‐Hodgkin's lymphoma, but the pathogenic mechanism remains obscure. HCV may infect B cells or interact with their cell surface receptors,